Torres Salazar, Benjamin O.
Dema, Taulant http://orcid.org/0000-0002-1932-2937
Schilling, Nadine A.
Janek, Daniela
Bornikoel, Jan http://orcid.org/0000-0002-9198-6025
Berscheid, Anne http://orcid.org/0000-0003-1585-8715
Elsherbini, Ahmed M. A. http://orcid.org/0000-0003-0267-4239
Krauss, Sophia
Jaag, Simon J. http://orcid.org/0000-0002-3847-774X
Lämmerhofer, Michael http://orcid.org/0000-0002-1318-0974
Li, Min
Alqahtani, Norah http://orcid.org/0000-0002-8056-5057
Horsburgh, Malcolm J. http://orcid.org/0000-0002-3806-0039
Weber, Tilmann http://orcid.org/0000-0002-8260-5120
Beltrán-Beleña, José Manuel http://orcid.org/0000-0002-8553-468X
Brötz-Oesterhelt, Heike http://orcid.org/0000-0001-9364-1832
Grond, Stephanie http://orcid.org/0000-0002-7549-4936
Krismer, Bernhard http://orcid.org/0000-0002-9505-8285
Peschel, Andreas http://orcid.org/0000-0002-3209-8626
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Cluster of Excellence EXC2124 Controlling Microbes to Fight Infection; project ID 390838134, ZUK 63, TRR261 (project ID 398967434), GRK1708, Cluster of Excellence EXC2124 Controlling Microbes to Fight Infection; project ID 390838134, TRR261 (project ID 398967434),GRK1708, Cluster of Excellence EXC2124 Controlling Microbes to Fight Infection; project ID 390838134, TRR261 (project ID 398967434), TRR156 (project ID 246807620), GRK1708)
Novo Nordisk Fonden (project ID NNF20CC0035580)
Article History
Received: 22 February 2022
Accepted: 3 November 2023
First Online: 18 December 2023
Competing interests
: The authors declare no competing interests.